This preclinical study demonstrates the potential of a drug repurposing strategy using the coadministration of tamsulosin, metoprolol, and bromocriptine to provide a mutation-agnostic therapy for inherited retinal degeneration.
- Henri Leinonen
- Jianye Zhang
- Krzysztof Palczewski